| Literature DB >> 26762501 |
Rashmi Sharma1, Mallikharjuna Rao Lambu2, Urmila Jamwal3, Chitra Rani1, Reena Chib4, Priya Wazir5, Debaraj Mukherjee2, Asha Chaubey6, Inshad Ali Khan7.
Abstract
Secondary metabolite of Aspergillus terreus, terreic acid, is a reported potent antibacterial that was identified more than 60 years ago, but its cellular target(s) are still unknown. Here we screen its activity against the acetyltransferase domain of a bifunctional enzyme, Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). An absorbance-based assay was used to screen terreic acid against the acetyltransferase activity of E. coli GlmU. Terreic acid was found to inhibit the acetyltransferase domain of E. coli GlmU with an IC50 of 44.24 ± 1.85 µM. Mode of inhibition studies revealed that terreic acid was competitive with AcCoA and uncompetitive with GlcN-1-P. It also exhibited concentration-dependent killing of E. coli ATCC 25922 up to 4× minimum inhibitory concentration and inhibited the growth of biofilms generated by E. coli. Characterization of resistant mutants established mutation in the acetyltransferase domain of GlmU. Terreic acid was also found to be metabolically stable in the in vitro incubations with rat liver microsome in the presence of a NADPH regenerating system. The studies reported here suggest that terreic acid is a potent antimicrobial agent and support that E. coli GlmU acetyltransferase is a molecular target of terreic acid, resulting in its antibacterial activity.Entities:
Keywords: ESBL; GlmU; acetyltransferase; drug resistance; lipopolysaccharide
Mesh:
Substances:
Year: 2016 PMID: 26762501 DOI: 10.1177/1087057115625308
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571